ARTICLE | Clinical News

MTC-DOX: Phase II/III

WIR Staff

November 25, 2002 8:00 AM UTC

FeRx started an international Phase II/III trial of MTC-DOX compared to intravenous doxyrubicin in 240 patients. ...

Get Unlimited Access

Continue reading with a free trial.